Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

PSE Product Makes “Highly” Tamper-Resistant Claim With 100% Out Of Reach

Jun 20 2014

• By Malcolm Spicer

Related Content

<em>Zephrex-D</em> Efficacy Claim Passes NAD Review After <em>Nexafed</em> Firm Objects

Jun 13 2014

Pseudoephedrine Will Be Behind The Counter Across The Country By October

Mar 06 2006

Nexafed Gains Rite Aid Sales, But Stumbles In Extraction-Proof PSE Tests

Nov 08 2013

Related Companies

Acura Pharmaceuticals, Inc.

Additional Topics

United States Business Strategies Advertising, Marketing & Sales Distribution Innovation Manufacturing Post Market Regulation & Studies Approvals Drug Approval Standards Regulation Compliance OTC Drugs Consumer

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window